share_log

Qiagen's (NYSE:QGEN) Investors Will Be Pleased With Their 15% Return Over the Last Five Years

Qiagen's (NYSE:QGEN) Investors Will Be Pleased With Their 15% Return Over the Last Five Years

Qiagen(纽约证券交易所代码:QGEN)的投资者将对过去五年中15%的回报感到满意
Simply Wall St ·  05/13 08:33

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Qiagen N.V. (NYSE:QGEN) share price is up 11% in the last five years, that's less than the market return. The last year has been disappointing, with the stock price down 6.7% in that time.

如果你买入并持有股票多年,你希望获利。此外,您通常希望看到股价的上涨速度快于市场。对于股东来说,不幸的是,尽管Qiagen N.V.(纽约证券交易所代码:QGEN)的股价在过去五年中上涨了11%,但仍低于市场回报率。去年令人失望,当时股价下跌了6.7%。

Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.

让我们来看看长期的基本面,看看它们是否与股东的回报一致。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

尽管一些人继续教导高效市场假说,但事实证明,市场是反应过度的动态系统,投资者并不总是理性的。通过比较每股收益(EPS)和一段时间内的股价变化,我们可以了解投资者对公司的态度是如何随着时间的推移而变化的。

Over half a decade, Qiagen managed to grow its earnings per share at 12% a year. The EPS growth is more impressive than the yearly share price gain of 2% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

在过去的五年中,Qiagen设法将其每股收益增长到每年12%。每股收益的增长比同期2%的年度股价增长更令人印象深刻。因此,人们可以得出结论,整个市场对该股变得更加谨慎。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下图中看到 EPS 随时间推移的变化(点击图表查看确切值)。

earnings-per-share-growth
NYSE:QGEN Earnings Per Share Growth May 13th 2024
纽约证券交易所:QGEN每股收益增长 2024年5月13日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. Dive deeper into the earnings by checking this interactive graph of Qiagen's earnings, revenue and cash flow.

可能值得注意的是,首席执行官的薪水低于类似规模公司的中位数。始终值得关注首席执行官的薪酬,但更重要的问题是公司多年来是否会增加收益。查看这张Qiagen收益、收入和现金流的交互式图表,深入了解收益。

What About The Total Shareholder Return (TSR)?

那么股东总回报(TSR)呢?

Investors should note that there's a difference between Qiagen's total shareholder return (TSR) and its share price change, which we've covered above. The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. We note that Qiagen's TSR, at 15% is higher than its share price return of 11%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

投资者应注意,Qiagen的股东总回报率(TSR)与其股价变动之间存在差异,我们在上面已经介绍了这一点。股东总回报率试图捕捉股息(就好像它们被再投资一样)以及向股东提供的任何分拆或折扣资本筹集的价值。我们注意到,Qiagen的股东总回报率为15%,高于其11%的股价回报率。当你考虑到它没有派发股息时,这些数据表明股东已经从分拆中受益,或者有机会通过折扣融资收购定价诱人的股票。

A Different Perspective

不同的视角

While the broader market gained around 28% in the last year, Qiagen shareholders lost 3.9%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 3% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. If you would like to research Qiagen in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

去年整体市场上涨了约28%,而Qiagen的股东却下跌了3.9%。但是,请记住,即使是最好的股票有时也会在十二个月内表现不如市场。好的一面是,长期股东赚了钱,在过去的五年中,每年增长3%。最近的抛售可能是一个机会,因此可能值得查看基本面数据以寻找长期增长趋势的迹象。如果你想更详细地研究Qiagen,那么你可能需要看看内部人士是否在买入或卖出该公司的股票。

We will like Qiagen better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我们看到一些重大的内幕收购,我们会更喜欢Qiagen。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发